Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesLaunching the Indian Generic Pharmaceutical Patent Academy
By Philip Brooks
GenericsWeb is thrilled to announce that the Generic Pharmaceutical Patent Academy is travelling to India for two events:
- 6th of October '08 at the Taj Krishna, Hyderabad
- 8th of October '08 at the Leela Kempinski, Mumbai
The Indian Patent Academy is a specially adapted one-day version of the full patent academy and will provide a global overview of patent protection in the generic pharmaceutical industry. The course will be delivered by industry experts Duncan Bucknell from Global IP Strategies and Leighton Howard CEO of GenericsWeb. This is an exciting opportunity for those in the generic pharmaceutical industry to improve their understanding and effectiveness in a rapidly evolving industry.
The Generic Pharmaceutical Patent Academy is a direct response to requests from generic drug development personnel to better understand and respond to patents. At no time in the past has the influence of patents been more significant on the industry, creating confusion and uncertainty with frightening regularity.
Established in 1999, GenericsWeb has customers in over 30 countries including legal practices, government departments, consultants and generic manufacturers. GenericsWeb?s Pipeline Patent Intelligence provides the most comprehensive, relevant and accurate patent information available which stem from GenericsWeb?s 100% dedication to the industry, extensive experience and investment in customer research.
See the full press release here.
Full post as published by Philip Brooks’ Patent Infringement Updates on September 16, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
US Settles Indian Lawsuit for $3.4 Billion
US Government Settles Indian Lawsuit for $3.4 Billion
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
ETHEX Corp
5 Generic Drugs Recalled Due to Risk of Death From Overdose
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Generic Versions
Barr Pharmaceuticals to pay $5.9 million settlement for blocking the sale of oral contraceptives.

Tussle Over Participation In India Compulsory Licence Hearing
US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil
Indian Generic Drug Maker Seeks to Invalidate Cancer Drug Patent
ACI Maximizing Pharmaceutical Patent Lifecycles Conference
Book Review: Generic Pharmaceutical Patent and FDA Law
Maximizing Pharmaceutical Patent Life Cycles








